This chemical is primarily utilized in the development of pharmaceuticals, particularly in the synthesis of compounds targeting central nervous system disorders. Its structure, featuring a piperazine ring, makes it valuable for creating molecules that interact with neurotransmitter receptors, potentially aiding in the treatment of conditions like anxiety, depression, or schizophrenia. Additionally, it serves as a key intermediate in the production of drugs designed to modulate serotonin or dopamine pathways, contributing to the advancement of psychotropic medications. Its application extends to research settings, where it is used to study receptor binding and signal transduction mechanisms, helping to identify new therapeutic targets.